DeepSight Technology, a pioneer in medical imaging, today announced the appointment of Steve Sapot as its new Vice President of Sales. In this role, Sapot will spearhead the company's commercial strategy, driving market adoption, partnerships, and customer engagement for DeepSight's cutting-edge ultrasound solutions, including the NeedleVue™ LC1 Ultrasound System that will work in tandem with the advanced interventional tool guidance and OnPoint™ Imaging that DeepSight is developing.

"We are thrilled to welcome Steve to the DeepSight leadership team," said Nader Sadrzadeh, Founder and CEO of DeepSight. "Steve brings deep experience in building and leading high-impact commercial organisations, establishing strategic partnerships, and achieving revenue growth in medical technology. His leadership will be instrumental as we gear up for commercialisation and broaden our clinical footprint."

Sapot brings over a decade of leadership experience across the medical device and imaging sectors. Most recently, he held the position of Chief Commercial Officer at Perimeter Medical Imaging AI, where he led its commercial operations from 2020, building market-ready teams and expanding commercial reach. Earlier, he served as Senior Vice President of Medical Sales at Faxitron (a Hologic company), where he managed nationwide capital equipment sales and contributed to launching its Breast Surgery franchise post-acquisition. His career also includes influential commercial roles at ConMed Electrosurgery and Barrx Medical, culminating in leadership across diverse sales and market environments.